EichorEICHOR
Location: Andalusia Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Andalusia

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · Amgen · NCT04528082
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Spanish Oncology Genito-Urinary Group · NCT06724159
Spanish Series of Patients Treated With the Radionuclide Lutetium177
Phase N/A · Sociedad Española de Medicina Nuclear e Imagen Molecular · NCT04949282
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433
Spanish Registry of Esophagogastric Cancer
Phase N/A · Fundación Sociedad Española de Oncologia Médica · NCT04958720
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Regeneron Pharmaceuticals · NCT06091865
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Bristol-Myers Squibb · NCT06976216
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · AstraZeneca · NCT06465810
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Amgen · NCT07005128
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1 · Regeneron Pharmaceuticals · NCT06975787
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Merck Sharp & Dohme LLC · NCT07489495
Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-O
Phase N/A · Oticon Medical · NCT06930781
A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcuta
Phase N/A · AbbVie · NCT07284342
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Kura Oncology, Inc. · NCT07007312
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Exciva GmbH · NCT07284472
Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligenc
Phase N/A · Alejandro Cruz Utrilla · NCT07236970
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Phase 2 · Abcentra · NCT06927739
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combinati
Phase 2 · AbbVie · NCT07155174
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Phase 1/Phase 2 · Merck Sharp & Dohme LLC · NCT06637423
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Pharmaceuticals · NCT05939414
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure
Phase 2 · Novo Nordisk A/S · NCT06979375
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · SEC Clinical Research LLC · Novartis Pharmaceuticals · NCT07517263
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Phase 1/Phase 2 · Stemline Therapeutics, Inc. · NCT05386108
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Phase 3 · Basilea Pharmaceutica · NCT06925321
Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest
Phase 2/Phase 3 · Gabriel Riva · NCT07174986
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Pfizer · NCT07222800
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
Phase 4 · Fundacion Clinic per a la Recerca Biomédica · NCT05398679
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NS
Phase 2 · CatalYm GmbH · NCT07098988
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymph
Phase 1/Phase 2 · Bristol-Myers Squibb · NCT06090539
Look up another city
Look up another condition